MICHAEL E LEE MD NPI 1225034507

NPI Information

  • NPI: 1225034507
  • Provider Name: MICHAEL E LEE, MD
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5900 LAKE WRIGHT DR
    NORFOLK, VA
    ZIP 23502
  • Phone: (757) 466-8683

Map and Directions

Get Directions

NPI Details

Michael E Lee, MD is a specialist in Norfolk, VA with 38 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. Michael E Lee, MD NPI is 1225034507. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

5900 LAKE WRIGHT DR
NORFOLK, VA
ZIP 23502-871
Phone: (757) 466-8683
Fax: (757) 466-8892

The NPI 1225034507 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Folic acid level, serum (HCPCS:82746)
  • Biopsy of bone marrow (HCPCS:38221)

The enumeration date for this NPI number is 6/22/2005 and was last updated on 11/29/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialist0101053330VIRGINIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1F82496MEDICARE UPINVIRGINIA
215867OTHERVIRGINIAOPTIMA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.